Quick onset of severe abdominal pain after codeine in an ultrarapid metabolizer of debrisoquine

Therapeutic Drug Monitoring

Volumn 19, Issue 5, 1997, Pages 543-544

  Dalén, Per ^a   Frengell, Camilla ^a   Dahl, Marja Liisa ^a   Sjöqvist, Folke ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cytochrome P 450; Genetics; Metabolism

Indexed keywords

CODEINE; DEBRISOQUINE; MORPHINE; PARACETAMOL;

ADULT; ARTICLE; CASE REPORT; DRUG METABOLISM; EPIGASTRIC PAIN; FEMALE; GENOTYPE; HUMAN; LOCAL ANESTHESIA; PHENOTYPE; PRIORITY JOURNAL;

EID: 0031405796     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199710000-00011     Document Type: Article

References (11)

1. Yue Q, Alm C, Svensson J-O, Sawe J. Quantification of the O- and N-demethylated and the glucuronidated metabolites of codeine in relation to the debrisoquine metabolic ratio in urine in ultrarapid, rapid and poor debrisoquine hydroxylators. Ther Drug Monit 1997;19(5).
2. Yue QY, Svensson J-O, Alm C, Sjöqvist F, Säwe J. Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation. Br J Clin Pharmacol 1989;28:639-45.
3. Evans DA, Mahgouh A, Sloan TP, Idle JR, Smith RL. A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population. J Med Genet 1980;17: 102-5.
4. Alván G, Bechtel P, Iselius L, Gundert-Remy U. Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations. Eur J Clin Pharmacnl 1990;39:533-7.
5. Dahl ML, Johansson I, Palmertz MP, Ingelman-Sundberg M, Sjöqvist F. Analysis of the CYP2D6 gene in relation to debrisoquin and desipramine hydroxylation in a Swedish population. Clin Pharmacol Ther 1992;51:12-7.
6. Bertilsson L, Dahl ML, Sjöqvist F, et al. Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine. Lancet 1993;341:63.
7. Johansson I, Lundqvist E, Bertilsson L, Dahl ML, Sjöqvist F, Ingelman-Sundberg M. Inherited amplification of an active gene in the cytochrome P450 CYP 2D locus as a cause of ultrarapid metabolism of debrisoquine. Proc Natl Acad Sci USA 1993;90: 11825-9.
8. Dahl ML, Johansson I, Bertilsson L, Ingelman-Sundberg M, Sjöqvist F. Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis. J Pharmacol Exp Ther 1995;274:516-20.
9. Heim M, Meyer UA. Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification. Lancet 1990;336:529-32.
10. Agundez JA, Ledesma MC, Ladero JM, Benitez J. Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white population. Clin Pharmacol Ther 1995;57: 265-9.
11. Aklillu E, Persson I, Bertilsson L, Johansson I, Rodrigues F, Ingelman-Sundberg M. Frequent distribution of ultrarapid metabolizers of debrisoquine in an Ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles. J Pharmacol Exp Ther 1996;278:441-6.